Results 91 to 100 of about 2,103,170 (215)

Intellectual Property and Public Health: An Overview of the Debate with a Focus on U.S. Policy [PDF]

open access: yes
Over the past fifteen years, the United States and other developed countries have employed trade agreements to substantially strengthen the protection of intellectual property rights for pharmaceutical products in the developing world.
Carsten Fink
core   +1 more source

Examining the Link Between Price Regulation, Reimportation, and Pharmaceutical R&D Investment [PDF]

open access: yes
This paper examines the link between price regulation and pharmaceutical research and development (R&D) investment. I identify two mechanisms through which price regulation (or re-importation) may exert an influence on R&D: an expected-profit effect and ...
Vernon, John
core   +1 more source

Pharmaceutical Analysis as a Branch of Pharmaceutics

open access: yesAmerican Journal of Pharmaceutical Education, 1977
openaire   +2 more sources

Inconsistencias conceptuales relacionadas con la utilización de los RNM

open access: yesPharmaceutical Care España, 2016
Fundación Pharmaceutical Care España -
doaj   +2 more sources

Overseas Acquisition versus Greenfield Foreign Investment: Which Internationalization Strategy is better for Indian Pharmaceutical Enterprises? [PDF]

open access: yes
Very recently overseas acquisition and outward greenfield foreign investment have emerged as the two important modes of internationalization of the Indian pharmaceutical enterprises.
Alakshendra, Abhinav   +1 more
core   +1 more source

Is Taking a Pill a Day Good for Health Expenditures? Evidence from a Cross Section Time Series Analysis of 19 OECD Countries from 1970 – 2000 [PDF]

open access: yes
This paper differs in two ways from previous comparative health system research. First, it focuses on the impact of pharmaceutical expenditures on total health expenditures as trends in pharmaceutical expenditures have been blamed of being a major driver
Verbelen, Bart
core  

Price and welfare effects of a pharmaceutical substitution reform [PDF]

open access: yes
The price effects of the Swedish pharmaceutical substitution reform are analyzed using data for a panel of all pharmaceutical product sold in Sweden in 1997—2007.
Granlund, David
core   +1 more source

Gene testing and prognosis in post-operative recurrent non-small-cell lung cancer: subgroup analyses of WJOG15421L. [PDF]

open access: yesESMO Open
Matsubara T   +20 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy